31
Views
0
CrossRef citations to date
0
Altmetric
Perspective

Lessons learnt: ophthalmology service organization, single-center experience from a COVID-19 highly affected area

, , , ORCID Icon, , , & show all
Pages 251-254 | Received 17 Nov 2020, Accepted 17 May 2021, Published online: 02 Jun 2021

References

  • General’s opening remarks at the media briefing on COVID19. WHO Director -March 11 2020; 2020. Available from:  https://www.who.int/covid-19/information
  • American Academy of Ophthalmologist (AAO). Important coronavirus updates of ophthalmologist.
  • Romano MR, Montericcio A, Montalbano C, et al. Facing COVID-19 in ophthalmology department. Curr Eye Res. 2020April;45:653–658.
  • Kissler SM, Tedijanto C, Goldstein E, et al. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period. Science. 2020April;368:860–868.
  • Signorelli C, Zucchi A, Tersalvi CA, et al. High seroprevalence of SARS_COV-2 in Bergamo: evidence for herd immunity or reason to be cautious? Int J Public Health. 2020;65(9):1815–1817.
  • Centers for Disease Control and Prevention (CDC). CDC telebriefing update on COVID-19; 2020. Available from: https://www.cdc.gov/media/releases/2020/t0225-cdc-telebriefing-covid-19.html.
  • Lai THT, Tang EWH, Chau SKY, et al. Stepping up infection control measures in ophthalmology during the novel coronavirus outbreak: an experience from Hong Kong. Graefe’s Arch Clin Exp Ophthalmol. 2020;258:1049–1055.
  • Xia J, Tong J, Liu M, et al. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol. 2020;0–3. DOI:10.1002/jmv.25725
  • European centre for disease prevention and control. Guidelines for the use of non-pharmaceutical measures to delay and mitigate the impact of 2019-nCoV. 2020 February.
  • Ferretti L, Wymant C, Kendall M, et al. Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing. Science. 2020;6936(March):eabb6936.
  • Kamel Boulos MN, Geraghty EM. Geographical tracking and mapping of coronavirus disease COVID-19/severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic and associated events around the world: how 21st century GIS technologies are supporting the global fight against outbr. Int J Health Geogr. 2020;19(1):8.
  • eHealth network. Mobile applications to support contact tracing in the EU’s fight against COVID-19 Common EU Toolbox for Member States; 2020:250–253.
  • immuni.italia.
  • Ijaz MK, Zargar B, Wright KE, et al. Generic aspects of the airborne spread of human pathogens indoors and emerging air decontamination technologies. Am J Infect Control. 2016;44(9 Suppl):S109–20.
  • Otter JA, Donskey C, Yezli S, et al. Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination. J Hosp Infect. 2016;92(3):235–250.
  • Van Doremalen N, Bushmaker T, Morris DH, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med. 2020;382:1564–1567.
  • Lai MYY, Cheng PKC, Lim WWL. Survival of severe acute respiratory syndrome coronavirus. Clin Infect Dis. 2005;41(7):e67–e71.
  • Tran K, Cimon K, Severn M, et al. Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review. PLoS One. 2012;7:4.
  • Liebmann JM. Ophthalmology and glaucoma practice in the COVID-19 era. J Glaucoma. 2020;29(6):407–408.
  • Lan L, Xu D, Ye G, et al. Positive RT-PCR test results in patients recovered from COVID-19. J Am Med Assoc. 2020;323(15):3–4.
  • Chadwick O, Lockington D. Addressing post-operative mask-associated dry eye (MADE). Eye (Lond). 2020 November;1-2: DOI:10.1038/s41433-020-01280-5
  • Huang HM, Chang DST, Wu PC. The association between near work activities and myopia in children - A systematic review and meta-analysis. PLoS One. 2015;10(10):1–15.
  • Pathipati AS, Wood EH, Lam CK, et al. Visual acuity measured with a smartphone app is more accurate than Snellen testing by emergency department providers. Graefes Arch Clin Exp Ophthalmol. 2016;254(6):1175–1180.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.